BD
Congress trade
Rep. Byron Donalds (R-FL) sold $1K-$15K of Abbott Laboratories (ABT) stock
Byron Donalds, U.S. Representative (R-FL), disclosed a sale of Abbott Laboratories (ABT) stock worth $1K-$15K in a STOCK Act filing on Jan 7, 2026.
The trade happened on Dec 4, 2025, 34 days before it was made public.
ABT has moved -19.5% since the trade date, from $125.40 to $100.98 (Sep 28, 2026 close).
- Traded
- Dec 4, 2025
- Disclosed
- Jan 7, 2026
- Filing delay
- 34 days
- Price since
- -19.5%
- Source
- STOCK Act disclosure
Other trades in this disclosure (3)
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.